ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target

Ageing Research Reviews

Volumn 24, Issue , 2015, Pages 111-125

  Nelson, Peter T ^a   Jicha, Gregory A ^a,b   Wang, Wang Xia ^a   Ighodaro, Eseosa ^a   Artiushin, Sergey ^a   Nichols, Colin G ^c   Fardo, David W ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Washington University School of Medicine ^*  (United States)

Author keywords

ABCC8; Arteriolosclerosis; GWAS; Hippocampus; Neuropathology; Oldest old; SUR1; SUR2A; SUR2Ab; SUR2B

Indexed keywords

ADENOSINE TRIPHOSPHATE; POLYPEPTIDE; POTASSIUM CHANNEL; SUR2 POLYPEPTIDE; UNCLASSIFIED DRUG; ABCC9 PROTEIN, HUMAN; SULFONYLUREA RECEPTOR;

ABCC9 GENE; ARTERIOLOSCLEROSIS; ASTROCYTE; BRAIN DISEASE; BRAIN NERVE CELL; BRAIN PERICYTE; CANTU SYNDROME; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; DEPRESSION; ENDOTHELIUM CELL; GENE; GENE FUNCTION; GENE MUTATION; GENETIC VARIABILITY; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPAL SCLEROSIS OF AGING; HISTOPATHOLOGY; HUMAN; MICROGLIA; OLIGODENDROGLIA; PHYLOGENY; PROTEIN FUNCTION; REVIEW; SLEEP DISORDER; VASCULAR SMOOTH MUSCLE CELL; AGING; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN DISEASES; CARDIOMEGALY; CHONDRODYSPLASIA; EXPERIMENTAL THERAPY; GENETICS; HIPPOCAMPUS; HYPERTRICHOSIS; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN DISEASES; CARDIOMEGALY; HIPPOCAMPUS; HUMANS; HYPERTRICHOSIS; MUTATION; OSTEOCHONDRODYSPLASIAS; SULFONYLUREA RECEPTORS; THERAPIES, INVESTIGATIONAL;

EID: 84961060846     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.07.007     Document Type: Review

References (239)

1. Adebiyi A., McNally E.M., Jaggar J.H. Vasodilation induced by oxygen/glucose deprivation is attenuated in cerebral arteries of SUR2 null mice. Am. J. Physiol. Heart Circ. Physiol. 2011, 301(4):H1360-H1368.
2. Aggarwal N.T., Pravdic D., McNally E.M., Bosnjak Z.J., Shi N.Q., Makielski J.C. The mitochondrial bioenergetic phenotype for protection from cardiac ischemia in SUR2 mutant mice. Am. J. Physiol. Heart Circ. Physiol. 2010, 299(6):H1884-H1890.
3. Aggarwal N.T., Shi N.Q., Makielski J.C. ATP-sensitive potassium currents from channels formed by Kir6 and a modified cardiac mitochondrial SUR2 variant. Channels 2013, 7(6):493-502.
4. Akasaka T., Klinedinst S., Ocorr K., Bustamante E.L., Kim S.K., Bodmer R. The ATP-sensitive potassium (KATP) channel-encoded dSUR gene is required for Drosophila heart function and is regulated by tinman. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(32):11999-12004.
5. Alkan T. Neuroproctective effects of ischemic tolerance (preconditioning) and postconditioning. Turkish Neurosurg. 2009, 19(4):406-412.
6. Allebrandt K.V., Amin N., Muller-Myhsok B., Esko T., Teder-Laving M., Azevedo R.V., Hayward C., van Mill J., Vogelzangs N., Green E.W., Melville S.A., Lichtner P., Wichmann H.E., Oostra B.A., Janssens A.C., Campbell H., Wilson J.F., Hicks A.A., Pramstaller P.P., Dogas Z., Rudan I., Merrow M., Penninx B., Kyriacou C.P., Metspalu A., van Duijn C.M., Meitinger T., Roenneberg T. A K(ATP) channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila. Mol. Psychiatry 2013, 18(1):122-132.
7. Amador-Ortiz C., Ahmed Z., Zehr C., Dickson D.W. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol. (Berl.) 2007, 113(3):245-252.
8. Amador-Ortiz C., Lin W.L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L., Dickson D.W. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 2007, 61(5):435-445.
9. Aoki N., Murray M.E., Ogaki K., Fujioka S., Rutherford N.J., Rademakers R., Ross O.A., Dickson D.W. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol. 2015, 129(1):53-64.
10. Armstead W.M. Brain injury impairs ATP-sensitive K+ channel function in piglet cerebral arteries. Stroke 1997, 28(11):2273.
11. Babenko A.P., Aguilar-Bryan L., Bryan J. A view of sur/KIR6. X, KATP channels. Annu. Rev. Physiol. 1998, 60:667-687.
12. Bao L., Taskin E., Foster M., Ray B., Rosario R., Ananthakrishnan R., Howlett S.E., Schmidt A.M., Ramasamy R., Coetzee W.A. Alterations in ventricular K(ATP) channel properties during aging. Aging Cell 2013, 12(1):167-176.
13. Barajas-Martinez H., Hu D., Ferrer T., Onetti C.G., Wu Y., Burashnikov E., Boyle M., Surman T., Urrutia J., Veltmann C., Schimpf R., Borggrefe M., Wolpert C., Ibrahim B.B., Sanchez-Chapula J.A., Winters S., Haissaguerre M., Antzelevitch C. Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. Heart Rhythm 2012, 9(4):548-555.
14. Beziau D.M., Barc J., O'Hara T., Le Gloan L., Amarouch M.Y., Solnon A., Pavin D., Lecointe S., Bouillet P., Gourraud J.B., Guicheney P., Denjoy I., Redon R., Mabo P., le Marec H., Loussouarn G., Kyndt F., Schott J.J., Probst V., Baro I. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. Basic Res. Cardiol. 2014, 109(6):446.
15. Bienengraeber M., Olson T.M., Selivanov V.A., Kathmann E.C., O'Cochlain F., Gao F., Karger A.B., Ballew J.D., Hodgson D.M., Zingman L.V., Pang Y.P., Alekseev A.E., Terzic A. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat. Genet. 2004, 36(4):382-387.
16. Bondjers C., He L., Takemoto M., Norlin J., Asker N., Hellstrom M., Lindahl P., Betsholtz C. Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes. FASEB 2006, 20(10):1703-1705.
17. Bonfanti D.H., Alcazar L.P., Arakaki P.A., Martins L.T., Agustini B.C., de Moraes Rego F.G., Frigeri H.R. ATP-dependent potassium channels and type 2 diabetes mellitus. Clin. Biochem. 2015.
18. Bouige P., Laurent D., Piloyan L., Dassa E. Phylogenetic and functional classification of ATP-binding cassette (ABC) systems. Curr. Protein Pept. Sci. 2002, 3(5):541-559.
19. Brenowitz W.D., Monsell S.E., Schmitt F.A., Kukull W.A., Nelson P.T. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J. Alzheimers Dis. 2014, 39(3):691-702.
20. Brown W.R., Thore C.R. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 2011, 37(1):56-74.
21. Brownstein C.A., Towne M.C., Luquette L.J., Harris D.J., Marinakis N.S., Meinecke P., Kutsche K., Campeau P.M., Yu T.W., Margulies D.M., Agrawal P.B., Beggs A.H. Mutation of KCNJ8 in a patient with Cantu syndrome with unique vascular abnormalities-support for the role of K(ATP) channels in this condition. Eur. J. Med. Genet. 2013, 56(12):678-682.
22. Bryan J., Munoz A., Zhang X., Dufer M., Drews G., Krippeit-Drews P., Aguilar-Bryan L. ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Archiv: Eur. J. Physiol. 2007, 453(5):703-718.
23. Busiah K., Drunat S., Vaivre-Douret L., Bonnefond A., Simon A., Flechtner I., Gerard B., Pouvreau N., Elie C., Nimri R., De Vries L., Tubiana-Rufi N., Metz C., Bertrand A.M., Nivot-Adamiak S., de Kerdanet M., Stuckens C., Jennane F., Souchon P.F., Le Tallec C., Desiree C., Pereira S., Dechaume A., Robert J.J., Phillip M., Scharfmann R., Czernichow P., Froguel P., Vaxillaire M., Polak M., Cave H., French N.D.M.s.g. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]. The lancet Diabetes Endocrinol. 2013, 1(3):199-207.
24. Busija D.W., Gaspar T., Domoki F., Katakam P.V., Bari F. Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv. Drug Deliv. Rev. 2008, 60(13-14):1471-1477.
25. Cai Y., Chai D., Pei F., Fang Y., Wang R., Liang B.B., Cui W.Y., Bao C.G., Wang H. Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers. J. Pharm. Pharmacol. 2012, 64(3):337-343.
26. Cameron J.S., DeWitt J.P., Ngo T.T., Yajnik T., Chan S., Chung E., Kang E. Cardiac K(ATP) channel alterations associated with acclimation to hypoxia in goldfish (Carassius auratus L.) Comparative biochemistry and physiology. Part A. Mol. Integr. Physiol. 2013, 164(4):554-564.
27. Cantu J.M., Garcia-Cruz D., Sanchez-Corona J., Hernandez A., Nazara Z. A distinct osteochondrodysplasia with hypertrichosis-individualization of a probable autosomal recessive entity. Hum. Genet. 1982, 60(1):36-41.
28. Cheng W.W., Tong A., Flagg T.P., Nichols C.G. Random assembly of SUR subunits in K(ATP) channel complexes. Channels 2008, 2(1):34-38.
29. Chutkow W.A., Makielski J.C., Nelson D.J., Burant C.F., Fan Z. Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J. Biol. Chem. 1999, 274(19):13656-13665.
30. Chutkow W.A., Pu J., Wheeler M.T., Wada T., Makielski J.C., Burant C.F., McNally E.M. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J. Clin. Investigation 2002, 110(2):203-208.
31. Chutkow W.A., Simon M.C., Le Beau M.M., Burant C.F. Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes 1996, 45(10):1439-1445.
32. Clement J.P.t., Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., Bryan J. Association and stoichiometry of K(ATP) channel subunits. Neuron 1997, 18(5):827-838.
33. Concolino D., Formicola S., Camera G., Strisciuglio P. Congenital hypertrichosis, cardiomegaly, and osteochondrodysplasia (Cantu syndrome): a new case with unusual radiological findings. Am. J. Med. Genet. 2000, 92(3):191-194.
34. Cooper P.E., Reutter H., Woelfle J., Engels H., Grange D.K., van Haaften G., van Bon B.W., Hoischen A., Nichols C.G. Cantu syndrome resulting from activating mutation in the KCNJ8 gene. Hum. Mutat. 2014, 35(7):809-813.
35. Costa A.D. Iptakalim: a new or just another KCO. Cardiovasc. Res. 2009, 83(3):417-418.
36. Croker B., Crozat K., Berger M., Xia Y., Sovath S., Schaffer L., Eleftherianos I., Imler J.L., Beutler B. ATP-sensitive potassium channels mediate survival during infection in mammals and insects. Nat. Genet. 2007, 39(12):1453-1460.
37. Cui J., Davidson A.L. ABC solute importers in bacteria. Essays Biochem. 2011, 50(1):85-99.
38. Czeschik J.C., Voigt C., Goecke T.O., Ludecke H.J., Wagner N., Kuechler A., Wieczorek D. Wide clinical variability in conditions with coarse facial features and hypertrichosis caused by mutations in ABCC9. Am. J. Med. Genet. A 2013, 161A(2):295-300.
39. Davidson Y.S., Raby S., Foulds P.G., Robinson A., Thompson J.C., Sikkink S., Yusuf I., Amin H., DuPlessis D., Troakes C., Al-Sarraj S., Sloan C., Esiri M.M., Prasher V.P., Allsop D., Neary D., Pickering-Brown S.M., Snowden J.S., Mann D.M. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol. 2011, 122(6):703-713.
40. Davis-Taber R., Choi W., Feng J., Hoogenboom L., McNally T., Kroeger P., Shieh C.C., Simmer R., Brioni J.D., Sullivan J.P., Gopalakrishnan M., Scott V.E. Molecular characterization of human SUR2-containing K(ATP) channels. Gene 2000, 256(1-2):261-270.
41. Davis F.B., Boh D.M., Davis P.J., van Son A.R., Mylotte K.M., Edwards L., Zielezny M., Sczupak C. Factors moderating the effect of oral sulfonylureas on free water clearance. J. Clin. Pharmacol. 1982, 22(2-3):97-101.
42. de Araujo E.D., Ikeda L.K., Tzvetkova S., Kanelis V. The first nucleotide binding domain of the sulfonylurea receptor 2A contains regulatory elements and is folded and functions as an independent module. Biochemistry 2011, 50(31):6655-6666.
43. de Weille J.R., Fosset M., Mourre C., Schmid-Antomarchi H., Bernardi H., Lazdunski M. Pharmacology and regulation of ATP-sensitive K+ channels. Pflugers Archiv: Eur. J. Physiol. 1989, 414(Suppl. 1):S80-S87.
44. Deming Y., Cruchaga C. TMEM106B: a strong FTLD disease modifier. Acta Neuropathol. 2014, 127(3):419-422.
45. Dermauw W., Osborne E.J., Clark R.M., Grbic M., Tirry L., Van Leeuwen T. A burst of ABC genes in the genome of the polyphagous spider mite Tetranychus urticae. BMC Genomics 2013, 14:317.
46. Dermauw W., Van Leeuwen T. The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance. Insect Biochem. Mol. Biol. 2014, 45:89-110.
47. Dickson D.W., Baker M., Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener. Dis. 2010, 7(1-3):170-174.
48. Dickson D.W., Davies P., Bevona C., Van Hoeven K.H., Factor S.M., Grober E., Aronson M.K., Crystal H.A. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol. 1994, 88(3):212-221.
49. Du Q., Jovanovic S., Tulic L., Sljivancanin D., Jack D.W., Zizic V., Abdul K.S., Tulic I., Jovanovic A. KATP channels are up-regulated with increasing age in human myometrium. Mech. Ageing Dev. 2013, 134(3-4):98-102.
50. Duan R.F., Cui W.Y., Wang H. Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6. 2 gene) polymorphisms in Chinese Han hypertensive patients. Acta Pharmacol. Sin. 2011, 32(8):1078-1084.
51. Edwards A.G., Rees M.L., Gioscia R.A., Zachman D.K., Lynch J.M., Browder J.C., Chicco A.J., Moore R.L. PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction. J. Physiol. 2009, 587(PART 23):5723-5737.
52. Efferth T. Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases. Ageing Res. Rev. 2003, 2(1):11-24.
53. Engels H., Bosse K., Ehrbrecht A., Zahn S., Hoischen A., Propping P., Bindl L., Reutter H. Further case of Cantu syndrome: exclusion of cryptic subtelomeric chromosome aberrations. Am. J. Med. Genet. 2002, 111(2):205-209.
54. Fahrenbach J.P., Stoller D., Kim G., Aggarwal N., Yerokun B., Earley J.U., Hadhazy M., Shi N.Q., Makielski J.C., McNally E.M. Abcc9 is required for the transition to oxidative metabolism in the newborn heart. FASEB 2014, 28(7):2804-2815.
55. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001, 64(6):575-611.
56. Fatima N., Schooley J.F., Claycomb W.C., Flagg T.P. Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes. PLoS ONE 2012, 7(7):e41533.
57. Flagg T.P., Enkvetchakul D., Koster J.C., Nichols C.G. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol. Rev. 2010, 90(3):799-829.
58. Flatt P.R., Shibier O., Szecowka J., Berggren P.O. New perspectives on the actions of sulphonylureas and hyperglycaemic sulphonamides on the pancreatic beta-cell. Diabete Metabolisme 1994, 20(2):157-162.
59. Florez J.C., Burtt N., de Bakker P.I., Almgren P., Tuomi T., Holmkvist J., Gaudet D., Hudson T.J., Schaffner S.F., Daly M.J., Hirschhorn J.N., Groop L., Altshuler D. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 2004, 53(5):1360-1368.
60. Fogal B., McClaskey C., Yan S., Yan H., Rivkees S.A. Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination. PLoS ONE 2010, 5(5):e10906.
61. Frey G., Lucht M., Schlue W.R. ATP-inhibited K+ channels and membrane potential of identified leech neurons. Brain Res. 1998, 798(1-2):247-253.
62. Furney S.J., Simmons A., Breen G., Pedroso I., Lunnon K., Proitsi P., Hodges A., Powell J., Wahlund L.O., Kloszewska I., Mecocci P., Soininen H., Tsolaki M., Vellas B., Spenger C., Lathrop M., Shen L., Kim S., Saykin A.J., Weiner M.W., Lovestone S. Alzheimer's disease neuroimaging, I., AddNeuroMed, C. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol. Psychiatry 2011, 16(11):1130-1138.
63. Gade A.R., Kang M., Akbarali H.I. Hydrogen sulfide as an allosteric modulator of ATP-sensitive potassium channels in colonic inflammation. Mol. Pharmacol. 2013, 83(1):294-306.
64. Gao J., Xu D., Sabat G., Valdivia H., Xu W., Shi N.Q. Disrupting KATP channels diminishes the estrogen-mediated protection in female mutant mice during ischemia-reperfusion. Clin. Proteomics 2014, 11(1):19.
65. Gao M., Xue H., Wang Y., Wang H. Iptakalim, opener of K(ATP), reverses the enhanced expression of genes encoding K(ATP) subunits in spontaneously hypertensive rats. Life Sci. 2005, 77(22):2743-2751.
66. Garcia-Cruz D., Sanchez-Corona J., Nazara Z., Garcia-Cruz M.O., Figuera L.E., Castaneda V., Cantu J.M. Congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly: further delineation of a new genetic syndrome. Am. J. Med. Genet. 1997, 69(2):138-151.
67. Garcia-Gonzalez C.L., Garcia-Cruz D., Garcia-Cruz M.O., Castaneda-Cisneros G., Garcia-Ortiz J.E., Orozco-Gutierrez M.H., Sanchez-Corona J. A familial case of Cantu craniofaciofronto digital syndrome. Clin. Dysmorphol. 2012, 21(3):162-166.
68. Giblin J.P., Cui Y., Clapp L.H., Tinker A. Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. J. Biol. Chem. 2002, 277(16):13717-13723.
69. Gloyn A.L., Weedon M.N., Owen K.R., Turner M.J., Knight B.A., Hitman G., Walker M., Levy J.C., Sampson M., Halford S., McCarthy M.I., Hattersley A.T., Frayling T.M. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003, 52(2):568-572.
70. Goodman Y., Mattson M.P. K+ channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity. Brain Res. 1996, 706(2):328-332.
71. Grange D.K., Lorch S.M., Cole P.L., Singh G.K. Cantu syndrome in a woman and her two daughters: Further confirmation of autosomal dominant inheritance and review of the cardiac manifestations. Am. J. Med. Genet. Part A 2006, 140(15):1673-1680.
72. Grange D.K., Nichols C.G., Singh G.K. Cantu Syndrome and Related Disorders 2014, GeneReviews(R), Seattle (WA). R.A. Pagon, M.P. Adam, H.H. Ardinger, T.D. Bird, C.R. Dolan, C.T. Fong, R.J.H. Smith, K. Stephens (Eds.).
73. Graziadio C., Rosa R.F., Rosa R.C., Zen P.R., Flores J.A., Paskulin G.A. Short-term follow-up of a Brazilian patient with Cantu syndrome. Am. J. Med. Genet. Part A 2011, 155A(5):1184-1188.
74. Haghverdizadeh P., Sadat Haerian M., Haghverdizadeh P., Sadat Haerian B. ABCC8 genetic variants and risk of diabetes mellitus. Gene 2014, 545(2):198-204.
75. Hamel E. The cerebral circulation: function and dysfunction in Alzheimer's disease. J. Cardiovas. Pharmacol. 2014.
76. Harakalova M., van Harssel J.J., Terhal P.A., van Lieshout S., Duran K., Renkens I., Amor D.J., Wilson L.C., Kirk E.P., Turner C.L., Shears D., Garcia-Minaur S., Lees M.M., Ross A., Venselaar H., Vriend G., Takanari H., Rook M.B., van der Heyden M.A., Asselbergs F.W., Breur H.M., Swinkels M.E., Scurr I.J., Smithson S.F., Knoers N.V., van der Smagt J.J., Nijman I.J., Kloosterman W.P., van Haelst M.M., van Haaften G., Cuppen E. Dominant missense mutations in ABCC9 cause Cantu syndrome. Nat. Genetics 2012, 44(7):793-796.
77. Heurteaux C., Bertaina V., Widmann C., Lazdunski M. K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 1993, 90(20):9431-9435.
78. Hicks G.A., Hudson A.L., Henderson G. Localization of high affinity [3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain. Neuroscience 1994, 61(2):285-292.
79. Hiraki Y., Miyatake S., Hayashidani M., Nishimura Y., Matsuura H., Kamada M., Kawagoe T., Yunoki K., Okamoto N., Yofune H., Nakashima M., Tsurusaki Y., Satisu H., Murakami A., Miyake N., Nishimura G., Matsumoto N. Aortic aneurysm and craniosynostosis in a family with Cantu syndrome. Am. J. Med. Genetics Part A 2014, 164A(1):231-236.
80. Hu D., Barajas-Martinez H., Terzic A., Park S., Pfeiffer R., Burashnikov E., Wu Y., Borggrefe M., Veltmann C., Schimpf R., Cai J.J., Nam G.B., Deshmukh P., Scheinman M., Preminger M., Steinberg J., Lopez-Izquierdo A., Ponce-Balbuena D., Wolpert C., Haissaguerre M., Sanchez-Chapula J.A., Antzelevitch C. ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int. J. Cardiol. 2014, 171(3):431-442.
81. Hu L.F., Wang S., Shi X.R., Yao H.H., Sun Y.H., Ding J.H., Liu S.Y., Hu G. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level. J. Neurochem. 2005, 94(6):1570-1579.
82. Hunter J.M., Kwan J., Malek-Ahmadi M., Maarouf C.L., Kokjohn T.A., Belden C., Sabbagh M.N., Beach T.G., Roher A.E. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS ONE 2012, 7(5):e36893.
83. Igarashi Y., Aoki K.F., Mamitsuka H., Kuma K., Kanehisa M. The evolutionary repertoires of the eukaryotic-type ABC transporters in terms of the phylogeny of ATP-binding domains in eukaryotes and prokaryotes. Mol. Biol. Evol. 2004, 21(11):2149-2160.
84. Inagaki N., Gonoi T., Clement J.P., Wang C.Z., Aguilar-Bryan L., Bryan J., Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 1996, 16(5):1011-1017.
85. Inoue H., Ferrer J., Warren-Perry M., Zhang Y., Millns H., Turner R.C., Elbein S.C., Hampe C.L., Suarez B.K., Inagaki N., Seino S., Permutt M.A. Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6. 2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 1997, 46(3):502-507.
86. Isomoto S., Kondo C., Yamada M., Matsumoto S., Higashiguchi O., Horio Y., Matsuzawa Y., Kurachi Y. A novel sulfonylurea receptor forms with BIR (Kir6. 2) a smooth muscle type ATP-sensitive K+ channel. J. Biol. Chem. 1996, 271(40):24321-24324.
87. Isomoto S., Kurachi Y. Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system. J. Cardiovasc. Electrophysiol. 1997, 8(12):1431-1446.
88. Jackson J.E., Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1. Drugs 1981, 22(3):211-245.
89. Jackson J.E., Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. Drugs 1981, 22(4):295-320.
90. Jansen-Olesen I., Mortensen C.H., El-Bariaki N., Ploug K.B. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression. Eur. J. Pharmacol. 2005, 523(1-3):109-118.
91. Jiang K., Yu Z., Shui Q. The pattern of ATP-sensitive K+ channel subunits, Kir6. 2 and SUR1 mRNA expressions in DG region is different from those in CA1-3 regions of chronic epilepsy induced by picrotoxin in rats. Neuropathology 2007, 27(6):531-538.
92. Kalaria R.N., Akinyemi R., Ihara M. Does vascular pathology contribute to Alzheimer changes. J. Neurol. Sci. 2012, 322(1-2):141-147.
93. Kamide K., Asayama K., Katsuya T., Ohkubo T., Hirose T., Inoue R., Metoki H., Kikuya M., Obara T., Hanada H., Thijs L., Kuznetsova T., Noguchi Y., Sugimoto K., Ohishi M., Morimoto S., Nakahashi T., Takiuchi S., Ishimitsu T., Tsuchihashi T., Soma M., Higaki J., Matsuura H., Shinagawa T., Sasaguri T., Miki T., Takeda K., Shimamoto K., Ueno M., Hosomi N., Kato J., Komai N., Kojima S., Sase K., Miyata T., Tomoike H., Kawano Y., Ogihara T., Rakugi H., Staessen J.A., Imai Y., Group G.s., Group H.-B.s. Genome-wide response to antihypertensive medication using home blood pressure measurements: a pilot study nested within the HOMED-BP study. Pharmacogenomics 2013, 14(14):1709-1721.
94. Kane G.C., Liu X.K., Yamada S., Olson T.M., Terzic A. Cardiac KATP channels in health and disease. Journal of molecular and cellular cardiology 2005, 38(6):937-943.
95. Kang M., Hashimoto A., Gade A.R., Akbarali H.I. Interaction between hydrogen sulfide-induced sulfhydration and tyrosine nitration in the KATP channel complex. Am. J. Physiol. 2014, 281:2014. Gastrointestinal and liver physiology, ajpgi.
96. Kawano T., Tanaka K., Chi H., Kimura M., Kawano H., Eguchi S., Oshita S. Effects of aging on isoflurane-induced and protein kinase A-mediated activation of ATP-sensitive potassium channels in cultured rat aortic vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 2010, 56(6):676-685.
97. Kim J.H., Cheong H.S., Sul J.H., Seo J.M., Kim D.Y., Oh J.T., Park K.W., Kim H.Y., Jung S.M., Jung K., Cho M.J., Bae J.S., Shin H.D. A genome-wide association study identifies potential susceptibility loci for Hirschsprung disease. PLoS ONE 2014, 9(10):e110292.
98. Kirsch T., Wellner M., Luft F.C., Haller H., Lippoldt A. Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res. 2001, 910(1-2):106-115.
99. Ko E.A., Han J., Jung I.D., Park W.S. Physiological roles of K+ channels in vascular smooth muscle cells. J. Smooth Muscle Res. 2008, 44(2):65-81. Nihon Heikatsukin Gakkai kikanshi.
100. Kobayashi D., Cook A.L., Williams D.A. Pulmonary hypertension secondary to partial pulmonary venous obstruction in a child with Cantu syndrome. Pediatr. Pulmonol. 2010, 45(7):727-729.
101. Kong M., Ba M. Protective effects of diazoxide against Abeta(2)(5)(-)(3)(5)-induced PC12 cell apoptosis due to prevention of endoplasmic reticulum stress. Neuroreport 2012, 23(8):493-497.
102. Koster J.C., Kurata H.T., Enkvetchakul D., Nichols C.G. DEND mutation in Kir6. 2 (KCNJ11) reveals a flexible N-terminal region critical for ATP-sensing of the KATP channel. Biophys. J. 2008, 95(10):4689-4697.
103. Kuslansky G., Verghese J., Dickson D., Katz M., Busche H., Lipton R.B. Hippocampal sclerosis: cognitive consequences and contribution to dementia. Neurology 2004, 62:A128-A129.
104. Lacza Z., Snipes J.A., Kis B., Szabo C., Grover G., Busija D.W. Investigation of the subunit composition and the pharmacology of the mitochondrial ATP-dependent K+ channel in the brain. Brain Res. 2003, 994(1):27-36.
105. Laukkanen O., Pihlajamaki J., Lindstrom J., Eriksson J., Valle T.T., Hamalainen H., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Tuomilehto J., Uusitupa M., Laakso M., Finnish Diabetes Prevention Study G. Polymorphisms of the SUR1 (ABCC8) and Kir6. 2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J. Clin. Endocrinol. Meta. 2004, 89(12):6286-6290.
106. Lazalde B., Sanchez-Urbina R., Nuno-Arana I., Bitar W.E., de Lourdes Ramirez-Duenas M. Autosomal dominant inheritance in Cantu syndrome (congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly). Am. J. Med. Genet. 2000, 94(5):421-427.
107. Lee C.R., Witkovsky P., Rice M.E. Regulation of Substantia Nigra Pars Reticulata GABAergic Neuron Activity by H(2)O(2) via Flufenamic Acid-Sensitive Channels and K(ATP) Channels. Front. Syst. Neurosci. 2011, 5:14.
108. Lee E.B., Lee V.M., Trojanowski J.Q., Neumann M. TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol 2008, 115(3):305-311.
109. Leverenz J.B., Lipton A.M. Clinical aspects of hippocampal sclerosis. Handb. Clin. Neurol. 2008, 89:565-567.
110. Li A., Knutsen R.H., Zhang H., Osei-Owusu P., Moreno-Dominguez A., Harter T.M., Uchida K., Remedi M.S., Dietrich H.H., Bernal-Mizrachi C., Blumer K.J., Mecham R.P., Koster J.C., Nichols C.G. Hypotension due to Kir6. 1 gain-of-function in vascular smooth muscle. J. Am. Heart Assoc. 2013, 2(4):e000365.
111. Liang G.H., Adebiyi A., Leo M.D., McNally E.M., Leffler C.W., Jaggar J.H. Hydrogen sulfide dilates cerebral arterioles by activating smooth muscle cell plasma membrane KATP channels. Am. J. Physiol. Heart Circ. Physiol. 2011, 300(6):H2088-H2095.
112. Light P. Regulation of ATP-sensitive potassium channels by phosphorylation. Biochim. Biophys. Acta 1996, 1286(1):65-73.
113. 2+-activated potassium channels. J. Cereb. Blood Flow Metab. 2003, 23:1227-1238.
114. Ling H., Holton J.L., Lees A.J., Revesz T. TDP -43 pathology is present in most post-encephalitic parkinsonism brains. Neuropathol. Appl. Neurobiol. 2013.
115. Liss B., Bruns R., Roeper J. Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J. 1999, 18(4):833-846.
116. Littleton J.T., Ganetzky B. Ion channels and synaptic organization: analysis of the Drosophila genome. Neuron 2000, 26(1):35-43.
117. Liu D., Lu C., Wan R., Auyeung W.W., Mattson M.P. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 2002, 22:431-443.
118. Liu D., Pitta M., Lee J.H., Ray B., Lahiri D.K., Furukawa K., Mughal M., Jiang H., Villarreal J., Cutler R.G., Greig N.H., Mattson M.P. The KATP channel activator diazoxide ameliorates amyloid-beta and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010, 22(2):443-457.
119. Liu D., Slevin J.R., Lu C., Chan S.L., Hansson M., Elmer E., Mattson M.P. Involvement of mitochondrial K+ release and cellular efflux in ischemic and apoptotic neuronal death. J. Neurochem. 2003, 86(4):966-979.
120. Liu Y., Ren G., O'Rourke B., Marban E., Seharaseyon J. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol. Pharmacol. 2001, 59(2):225-230.
121. Lodwick D., Rainbow R.D., Rubaiy H.N., Al Johi M., Vuister G.W., Norman R.I. Sulfonylurea receptors regulate the channel pore in ATP-sensitive potassium channels via an intersubunit salt bridge. Biochem. J. 2014, 464(3):343-354.
122. Lu M., Yang J.Z., Geng F., Ding J.H., Hu G. Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis. Int. J. Neuro. 2014, 17(9):1501-1510.
123. Ma G., Fu Q., Zhang Y., Gao J., Jiang J., Bi A., Liu K., Du Y., Chen C., Cui Y., Lu L. Effects of Abeta1-42 on the subunits of KATP expression in cultured primary rat basal forebrain neurons. Neurochem. Re.s 2008, 33(7):1419-1424.
124. Ma G., Gao J., Fu Q., Jiang L., Wang R., Zhang Y., Liu K. Diazoxide reverses the enhanced expression of KATP subunits in cholinergic neurons caused by exposure to Abeta(1)(-)(4)(2). Neurochem. Res. 2009, 34(12):2133-2140.
125. Maack C., Dabew E.R., Hohl M., Schafers H.J., Bohm M. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning. Circ. Res. 2009, 105(8):811-817.
126. Macauley S.L., Stanley M., Caesar E.E., Yamada S.A., Raichle M.E., Perez R., Mahan T.E., Sutphen C.L., Holtzman D.M. Hyperglycemia modulates extracellular amyloid-beta concentrations and neuronal activity in vivo. J. Clin. Invest. 2015, 125(6):2463-2467.
127. MacCormack T.J., Driedzic W.R. Mitochondrial ATP-sensitive K+ channels influence force development and anoxic contractility in a flatfish, yellowtail flounder Limanda ferruginea, but not Atlantic cod Gadus morhua heart. J. Exp. Biology 2002, 205(PART 10):1411-1418.
128. McKee A.C., Gavett B.E., Stern R.A., Nowinski C.J., Cantu R.C., Kowall N.W., Perl D.P., Hedley-Whyte E.T., Price B., Sullivan C., Morin P., Lee H.S., Kubilus C.A., Daneshvar D.H., Wulff M., Budson A.E. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 2010, 69(9):918-929.
129. Mehta R.I., Ivanova S., Tosun C., Castellani R.J., Gerzanich V., Simard J.M. Sulfonylurea receptor 1 expression in human cerebral infarcts. J. Neuropathol. Exp. Neurol. 2013, 72(9):871-883.
130. Melander A., Bitzen P.O., Faber O., Groop L. Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. Drugs 1989, 37(1):58-72.
131. Miki T., Suzuki M., Shibasaki T., Uemura H., Sato T., Yamaguchi K., Koseki H., Iwanaga T., Nakaya H., Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat. Med. 2002, 8(5):466-472.
132. Minami K., Miki T., Kadowaki T., Seino S. Roles of ATP-sensitive K+ channels as metabolic sensors: studies of Kir6. x null mice. Diabetes 2004, 53(Suppl. 3):S176-80.
133. Minoretti P., Falcone C., Aldeghi A., Olivieri V., Mori F., Emanuele E., Calcagnino M., Geroldi D. A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction. Clin. Chim. Acta 2006, 370(1-2):124-128.
134. Miralles M.J., McGinty J.W., Martin A. Combined water-soluble carriers for coprecipitates of tolbutamide. J. Pharm. Sci. 1982, 71(3):302-304.
135. Misler S., Giebisch G. ATP-sensitive potassium channels in physiology, pathophysiology, and pharmacology. Curr. Opin. Nephrol. Hypertens. 1992, 1(1):21-33.
136. Montagne A., Barnes S.R., Sweeney M.D., Halliday M.R., Sagare A.P., Zhao Z., Toga A.W., Jacobs R.E., Liu C.Y., Amezcua L., Harrington M.G., Chui H.C., Law M., Zlokovic B.V. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015, 85(2):296-302.
137. Montine T.J., Koroshetz W.J., Babcock D., Dickson D.W., Galpern W.R., Glymour M.M., Greenberg S.M., Hutton M.L., Knopman D.S., Kuzmichev A.N., Manly J.J., Marder K.S., Miller B.L., Phelps C.H., Seeley W.W., Sieber B.A., Silverberg N.B., Sutherland M., Torborg C.L., Waddy S.P., Zlokovic B.V., Corriveau R.A., Committee A.C.O. Recommendations of the Alzheimer's disease-related dementias conference. Neurology 2014, 83(9):851-860.
138. Montine T.J., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., Duyckaerts C., Frosch M.P., Masliah E., Mirra S.S., Nelson P.T., Schneider J.A., Thal D.R., Trojanowski J.Q., Vinters H.V., Hyman B.T., National Institute on A., Alzheimer's A. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012, 123(1):1-11.
139. Murray M.E., Cannon A., Graff-Radford N.R., Liesinger A.M., Rutherford N.J., Ross O.A., Duara R., Carrasquillo M.M., Rademakers R., Dickson D.W. Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol. 2014.
140. Nag S., Yu L., Capuano A.W., Wilson R.S., Leurgans S.E., Bennett D.A., Schneider J.A. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer's Disease. Ann Neurol. 2015.
141. Nasonkin I., Alikasifoglu A., Ambrose C., Cahill P., Cheng M., Sarniak A., Egan M., Thomas P.M. A novel sulfonylurea receptor family member expressed in the embryonic Drosophila dorsal vessel and tracheal system. J. Biol. Chem. 1999, 274(41):29420-29425.
142. Nelson P.T., Abner E.L., Schmitt F.A., Kryscio R.J., Jicha G.A., Smith C.D., Davis D.G., Poduska J.W., Patel E., Mendiondo M.S., Markesbery W.R. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol. 2010, 20(1):66-79.
143. Nelson P.T., Estus S., Abner E.L., Parikh I., Malik M., Neltner J.H., Ighodaro E., Wang W.X., Wilfred B.R., Wang L.S., Kukull W.A., Nandakumar K., Farman M.L., Poon W.W., Corrada M.M., Kawas C.H., Cribbs D.H., Bennett D.A., Schneider J.A., Larson E.B., Crane P.K., Valladares O., Schmitt F.A., Kryscio R.J., Jicha G.A., Smith C.D., Scheff S.W., Sonnen J.A., Haines J.L., Pericak-Vance M.A., Mayeux R., Farrer L.A., Van Eldik L.J., Horbinski C., Green R.C., Gearing M., Poon L.W., Kramer P.L., Woltjer R.L., Montine T.J., Partch A.B., Rajic A.J., Richmire K., Monsell S.E., Alzheimer' Disease Genetic C., Schellenberg G.D., Fardo D.W. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 2014, 127(6):825-843.
144. Nelson P.T., Keller J.N. RNA in brain disease: no longer just the messenger in the middle. J. Neuropathol. Exp. Neurol. 2007, 66(6):461-468.
145. Nelson P.T., Schmitt F.A., Lin Y., Abner E.L., Jicha G.A., Patel E., Thomason P.C., Neltner J.H., Smith C.D., Santacruz K.S., Sonnen J.A., Poon L.W., Gearing M., Green R.C., Woodard J.L., Van Eldik L.J., Kryscio R.J. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011, 134(PART 5):1506-1518.
146. Nelson P.T., Smith C.D., Abner E.L., Wilfred B.J., Wang W.X., Neltner J.H., Baker M., Fardo D.W., Kryscio R.J., Scheff S.W., Jicha G.A., Jellinger K.A., Van Eldik L.J., Schmitt F.A. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol. 2013, 126(2):161-177.
147. Nelson P.T., Wang W.X., Partch A.B., Monsell S.E., Valladares O., Ellingson S.R., Wilfred B.R., Naj A.C., Wang L.S., Kukull W.A., Fardo D.W. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J. Neuropathol. Exp. Neurol. 2015, 74(1):75-84.
148. Nelson P.T., Wang W.X., Wilfred B.R., Wei A., Dimayuga J., Huang Q., Ighodaro E., Artiushin S., Fardo D.W. Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of aging. J. Neurochem. 2015, (June). PMID: 26115089. 10.1111/jnc.13202.
149. Neltner J.H., Abner E.L., Baker S., Schmitt F.A., Kryscio R.J., Jicha G.A., Smith C.D., Hammack E., Kukull W.A., Brenowitz W.D., Van Eldik L.J., Nelson P.T. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 2014, 137(1):255-267.
150. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-4in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314(5796):130-133.
151. Nevin N.C., Mulholland H.C., Thomas P.S. Congenital hypertrichosis, cardiomegaly and mild osteochondrodysplasia. Am. J. Med. Genet. 1996, 66(1):33-38.
152. Nichols C.G. KATP channels as molecular sensors of cellular metabolism. Nature 2006, 440(7083):470-476.
153. Nichols C.G., Singh G.K., Grange D.K. KATP channels and cardiovascular disease: suddenly a syndrome. Circ. Res. 2013, 112(7):1059-1072.
154. Nielsen E.M., Hansen L., Carstensen B., Echwald S.M., Drivsholm T., Glumer C., Thorsteinsson B., Borch-Johnsen K., Hansen T., Pedersen O. The E23K variant of Kir6. 2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003, 52(2):573-577.
155. Nishimura M., Ocorr K., Bodmer R., Cartry J. Drosophila as a model to study cardiac aging. Exp. Gerontol. 2011, 46(5):326-330.
156. Ocorr K., Perrin L., Lim H.Y., Qian L., Wu X., Bodmer R. Genetic control of heart function and aging in Drosophila. Trends Cardiovasc. Med. 2007, 17(5):177-182.
157. Olson T.M., Alekseev A.E., Moreau C., Liu X.K., Zingman L.V., Miki T., Seino S., Asirvatham S.J., Jahangir A., Terzic A. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(2):110-116.
158. Olson T.M., Terzic A. Human K(ATP) channelopathies: diseases of metabolic homeostasis. Pflugers Archiv: Eur. J. Physiol. 2010, 460(2):295-306.
159. Ortega F.J., Gimeno-Bayon J., Espinosa-Parrilla J.F., Carrasco J.L., Batlle M., Pugliese M., Mahy N., Rodriguez M.J. ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats. Exp. Neurol. 2012, 235(1):282-296.
160. Pao W.C., Dickson D.W., Crook J.E., Finch N.A., Rademakers R., Graff-Radford N.R. Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis. Assoc. Disorders 2011, 25(4):364-368.
161. Park J.Y., Koo S.H., Jung Y.J., Lim Y.J., Chung M.L. A patient with Cantu syndrome associated with fatal bronchopulmonary dysplasia and pulmonary hypertension. Am. J. Med. Genet. Part A 2014, 164A(8):2118-2120.
162. Park S., Lim B.B., Perez-Terzic C., Mer G., Terzic A. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity. J. Proteome Pes. 2008, 7(4):1721-1728.
163. Park S., Terzic A. Quaternary structure of KATP channel SUR2A nucleotide binding domains resolved by synchrotron radiation X-ray scattering. J. Struct. Biol. 2010, 169(2):243-251.
164. Parsons M.J., Lester K.J., Barclay N.L., Nolan P.M., Eley T.C., Gregory A.M. Replication of Genome-Wide Association Studies (GWAS) loci for sleep in the British G1219 cohort. Am. J. Med. Genet. Part B 2013, 162B(5):431-438.
165. Ploug K.B., Baun M., Hay-Schmidt A., Olesen J., Jansen-Olesen I. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues. Eur. J. Pharmacol. 2010, 637(1-3):109-117.
166. Ploug K.B., Edvinsson L., Olesen J., Jansen-Olesen I. Pharmacological and molecular comparison of K(ATP) channels in rat basilar and middle cerebral arteries. Eur. J. Pharmacol. 2006, 553(1-3):254-262.
167. Ploug K.B., Sorensen M.A., Strobech L., Klaerke D.A., Hay-Schmidt A., Sheykhzade M., Olesen J., Jansen-Olesen I. K ATP channels in pig and human intracranial arteries. Eur. J. Pharmacol. 2008, 601(1-3):43-49.
168. Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., Lincoln S.J., Finch N., Rutherford N.J., Crook R.J., Josephs K.A., Boeve B.F., Knopman D.S., Petersen R.C., Parisi J.E., Caselli R.J., Wszolek Z.K., Uitti R.J., Feldman H., Hutton M.L., Mackenzie I.R., Graff-Radford N.R., Dickson D.W. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008, 17(23):3631-3642.
169. Rana A., Goyal N., Ahlawat A., Jamwal S., Reddy B., Sharma S. Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders. Perfusion 2015, 30(2):94-105.
170. Reed B.R., Mungas D.M., Kramer J.H., Ellis W., Vinters H.V., Zarow C., Jagust W.J., Chui H.C. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 2007, 130(PART 3):731-739.
171. Remedi M.S., Nichols C.G. Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice. Cell Metab. 2009, 10(6):442-453.
172. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245(4922):1066-1073.
173. Robertson S.P., Kirk E., Bernier F., Brereton J., Turner A., Bankier A. Congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly: Cantu syndrome. Am. J. Med. Genet. 1999, 85(4):395-402.
174. Rosser E.M., Kaariainen H., Hurst J.A., Baraitser M., Hall C.M., Clayton P., Leonard J.V. Three patients with the osteochondrodysplasia and hypertrichosis syndrome-Cantu syndrome. Clin. Dysmorphol. 1998, 7(2):79-85.
175. Sagare A.P., Bell R.D., Zhao Z., Ma Q., Winkler E.A., Ramanathan A., Zlokovic B.V. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 2013, 4:2932.
176. Salgado D., Shek E.W., Alkadhi K.A. Effects of ATP-sensitive K(+)-channel activators on transmitter release parameters at the frog neuromuscular junction. Brain Res. 1993, 609(1-2):307-312.
177. Sanada S., Kitakaze M. Ischemic preconditioning: emerging evidence, controversy, and translational trials. Int. J. Cardiol. 2004, 97(2):263-276.
178. Sato N., Nakayama T., Asai S., Soma M. A haplotype in the human Sur2 gene is associated with essential hypertension. J. Hum. Hypertens. 2006, 20(1):87-90.
179. Scurr I., Wilson L., Lees M., Robertson S., Kirk E., Turner A., Morton J., Kidd A., Shashi V., Stanley C., Berry M., Irvine A.D., Goudie D., Turner C., Brewer C., Smithson S. Cantu syndrome: report of nine new cases and expansion of the clinical phenotype. Am. J. Med. Genet. Part A 2011, 155A(3):508-518.
180. Seino S., Iwanaga T., Nagashima K., Miki T. Diverse roles of K(ATP) channels learned from Kir6. 2 genetically engineered mice. Diabetes 2000, 49(3):311-318.
181. Seino S., Miki T. Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog. Biophys. Mol. Biol. 2003, 81(2):133-176.
182. Shi N.Q., Ye B., Makielski J.C. Function and distribution of the SUR isoforms and splice variants. J. Mol. Cell. Cardiol. 2005, 39(1):51-60.
183. Shi W.W., Yang Y., Shi Y., Jiang C. K(ATP) channel action in vascular tone regulation: from genetics to diseases. Sheng li xue bao: [Acta Physiol. Sinica] 2012, 64(1):1-13.
184. Shyng S., Nichols C.G. Octameric stoichiometry of the KATP channel complex. J. Gen. Physiol. 1997, 110(6):655-664.
185. Sikka P., Kapoor S., Bindra V.K., Saini M., Saxena K.K. Iptakalim: a novel multi-utility potassium channel opener. J. Pharmacol. Pharmacotherapeutics 2012, 3(1):12-14.
186. Simard J.M., Castellani R.J., Ivanova S., Koltz M.T., Gerzanich V. Sulfonylurea receptor 1 in the germinal matrix of premature infants. Pediatr. Res. 2008, 64(6):648-652.
187. Simard J.M., Woo S.K., Bhatta S., Gerzanich V. Drugs acting on SUR1 to treat CNS ischemia and trauma. Curr. Opin. Pharmacol. 2008, 8(1):42-49.
188. Simard J.M., Woo S.K., Schwartzbauer G.T., Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J. Cereb. Blood Flow Metab. 2012, 32(9):1699-1717.
189. Smith A.J., Taneja T.K., Mankouri J., Sivaprasadarao A. Molecular cell biology of KATP channels: implications for neonatal diabetes. Expert Rev. Mol. Med. 2007, 9(21):1-17.
190. Smith K.J., Chadburn A.J., Adomaviciene A., Minoretti P., Vignali L., Emanuele E., Tammaro P. Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9. Int. J. Cardiol. 2013, 168(4):3506-3513.
191. Snyder H.M., Corriveau R.A., Craft S., Faber J.E., Greenberg S.M., Knopman D., Lamb B.T., Montine T.J., Nedergaard M., Schaffer C.B., Schneider J.A., Wellington C., Wilcock D.M., Zipfel G.J., Zlokovic B., Bain L.J., Bosetti F., Galis Z.S., Koroshetz W., Carrillo M.C. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement 2014.
192. Solbach T.F., Konig J., Fromm M.F., Zolk O. ATP-binding cassette transporters in the heart. Trends Cardiovas. Med. 2006, 16(1):7-15.
193. Standen N.B., Quayle J.M. K+ channel modulation in arterial smooth muscle. Acta Physiol. Scand. 1998, 164(4):549-557.
194. Stowers J.M., Borthwick L.J. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use. Drugs 1977, 14(1):41-56.
195. Sturm A., Cunningham P., Dean M. The ABC transporter gene family of Daphnia pulex. BMC Geno. 2009, 10:170.
196. Sun X.L., Hu G. ATP-sensitive potassium channels: a promising target for protecting neurovascular unit function in stroke. Clin. Exp. Pharmacol. Physiol. 2010, 37(2):243-252.
197. Sun X.L., Zeng X.N., Zhou F., Dai C.P., Ding J.H., Hu G. KATP channel openers facilitate glutamate uptake by GluTs in rat primary cultured astrocytes. Neuropsychopharmacology 2008, 33(6):1336-1342.
198. Tanner G.R., Lutas A., Martinez-Francois J.R., Yellen G. Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J. Neurosci. 2011, 31(23):8689-8696.
199. Tosun C., Kurland D.B., Mehta R., Castellani R.J., deJong J.L., Kwon M.S., Woo S.K., Gerzanich V., Simard J.M. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke 2013, 44(12):3522-3528.
200. Toyoda K., Fujii K., Takata Y., Ibayashi S., Kitazono T., Nagao T., Fujikawa M., Fujishima M. Age-related changes in response of brain stem vessels to opening of ATP-sensitive potassium channels. Stroke 1997, 28(1):171-175.
201. Tricarico D., Petruzzi R., Conte Camerino D.C. Different sulfonylurea and ATP sensitivity characterizes the juvenile and the adult form of KATP channel complex of rat skeletal muscle. Eur. J. Pharmacol. 1997, 321(3):369-378.
202. Trimmer J.S. Subcellular localization of K channels in mammalian brain neurons: remarkable precision in the midst of extraordinary complexity. Neuron 2015, 85(2):238-256.
203. Tu I.H., Yen H.T., Cheng H.W., Chiu J.H. Baicalein protects chicken embryonic cardiomyocyte against hypoxia-reoxygenation injury via mu- and delta- but not kappa-opioid receptor signaling. Eur. J. Pharmacol. 2008, 588(2-3):251-258.
204. Vajapey R., Rini D., Walston J., Abadir P. The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance. Front. Physiol. 2014, 5:439.
205. van Bon B.W., Gilissen C., Grange D.K., Hennekam R.C., Kayserili H., Engels H., Reutter H., Ostergaard J.R., Morava E., Tsiakas K., Isidor B., Le Merrer M., Eser M., Wieskamp N., de Vries P., Steehouwer M., Veltman J.A., Robertson S.P., Brunner H.G., de Vries B.B., Hoischen A. Cantu syndrome is caused by mutations in ABCC9. Am. J. Hum. Genet. 2012, 90(6):1094-1101.
206. van Dam R.M., Hoebee B., Seidell J.C., Schaap M.M., de Bruin T.W., Feskens E.J. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabetic Med.: J. Br. Diabetic Assoc. 2005, 22(5):590-598.
207. Van Deerlin V.M., Wood E.M., Moore P., Yuan W., Forman M.S., Clark C.M., Neumann M., Kwong L.K., Trojanowski J.Q., Lee V.M., Grossman M. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch. Neurol. 2007, 64(8):1148-1153.
208. Volf N., Hu G., Li M. Iptakalim preferentially decreases nicotine-induced hyperlocomotion in phencyclidine-sensitized rats: a potential dual action against nicotine addiction and psychosis. Clin. Psychopharmacol. Neurosci. 2012, 10(3):168-179.
209. Walker A.K., Daniels C.M., Goldman J.E., Trojanowski J.Q., Lee V.M., Messing A. Astrocytic TDP-43 pathology in Alexander disease. J. Neurosci. 2014, 34(19):6448-6458.
210. Wang H., Long C.L., Zhang Y.L. A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension. J. Pharmacol. Exp. Therapeutics 2005, 312(3):1326-1333.
211. Wang H., Zhang Y.L., Chen Y.P. Targeting small arteries of hypertensive status with novel ATP-sensitive potassium channel openers. Curr. Vasc. Pharmacol. 2005, 3(2):119-124.
212. Wang H., Zhang Y.L., Tang X.C., Feng H.S., Hu G. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain. Mol. Pharmacol. 2004, 66(5):1160-1168.
213. Wang J.F., Li Y., Song J.N., Pang H.G. Role of hydrogen sulfide in secondary neuronal injury. Neurochem. Int. 2014, 64:37-47.
214. Wang S., Hu L.F., Yang Y., Ding J.H., Hu G. Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease. Neuropharmacology 2005, 48(7):984-992.
215. Wang S., Hu L.F., Zhang Y., Sun T., Sun Y.H., Liu S.Y., Ding J.H., Wu J., Hu G. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats. Neuropsychopharmacology 2006, 31(5):933-940.
216. Weller R.O., Hawkes C.A., Carare R.O., Hardy J. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Abeta and propagation of tau?. Acta Neuropathol. 2015, 129(5):763-766.
217. Wheeler A., Wang C., Yang K., Fang K., Davis K., Styer A.M., Mirshahi U., Moreau C., Revilloud J., Vivaudou M., Liu S., Mirshahi T., Chan K.W. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels. Mol. Pharmacol. 2008, 74(5):1333-1344.
218. White L., Petrovitch H., Hardman J., Nelson J., Davis D.G., Ross G.W., Masaki K., Launer L., Markesbery W.R. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann. N. Y. Acad. Sci. 2002, 977:9-23.
219. Wu C.W., Leung C.K., Yung W.H. Sulphonylureas reverse hypoxia induced K(+)-conductance increase in substantia nigra pars reticulata neurones. Neuroreport 1996, 7(15-17):2513-2517.
220. Xie J., Duan L., Qian X., Huang X., Ding J., Hu G. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. J. Neurosci. Res. 2010, 88(2):428-437.
221. Xie X., Cheng T., Wang G., Duan J., Niu W., Xia Q. Genome-wide analysis of the ATP-binding cassette (ABC) transporter gene family in the silkworm, Bombyx mori. Mol. Biol. Rep. 2012, 39(7):7281-7291.
222. Yamada M., Isomoto S., Matsumoto S., Kondo C., Shindo T., Horio Y., Kurachi Y. Sulphonylurea receptor 2B and Kir6. 1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J. Physiol. 1997, 499(PART 3):715-720.
223. Yang Y., Liu X., Ding J.H., Sun J., Long Y., Wang F., Yao H.H., Hu G. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells. Neurosci. Lett. 2004, 366(1):53-57.
224. Yang Y., Liu X., Long Y., Wang F., Ding J.H., Liu S.Y., Sun Y.H., Yao H.H., Wang H., Wu J., Hu G. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats. J. Neurosci. Res. 2005, 80(3):442-449.
225. Yang Y.J., Zhang S., Ding J.H., Zhou F., Hu G. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation. Int. J. Neuropsychopharmacol. 2009, 12(3):317-327.
226. Ye B., Kroboth S.L., Pu J.L., Sims J.J., Aggarwal N.T., McNally E.M., Makielski J.C., Shi N.Q. Molecular identification and functional characterization of a mitochondrial sulfonylurea receptor 2 splice variant generated by intraexonic splicing. Circ. Res. 2009, 105(11):1083-1093.
227. Yoshida H., Feig J.E., Morrissey A., Ghiu I.A., Artman M., Coetzee W.A. K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6. 1, Kir6. 2, and SUR2B subunits. J. Mol. Cell. Cardiol. 2004, 37(4):857-869.
228. Yu L., De Jager P.L., Yang J., Trojanowski J.Q., Bennett D.A., Schneider J.A. The TMEM106B locus and TDP -43 pathology in older persons without FTLD. Neurology 2015.
229. Yuan H.B., Huang Y., Zheng S., Zuo Z. Hypothermic preconditioning increases survival of purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia. Anesthesiology 2004, 100(2):331-337.
230. Zarow C., Sitzer T.E., Chui H.C. Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr. Neurol. Neurosci. Rep. 2008, 8(5):363-370.
231. Zarow C., Weiner M.W., Ellis W.G., Chui H.C. Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav. 2012, 2(4):435-442.
232. Zawar C., Plant T.D., Schirra C., Konnerth A., Neumcke B. Cell-type specific expression of ATP-sensitive potassium channels in the rat hippocampus. J. Physiol. 1999, 514(PART 2):327-341.
233. Zhang S., Liang R., Zhou F., Huang X., Ding J.H., Hu G. Reversal of rotenone-induced dysfunction of astrocytic connexin43 by opening mitochondrial ATP-sensitive potassium channels. Cell. Mol. Neurobiol. 2011, 31(1):111-117.
234. Zhou F., Wu J.Y., Sun X.L., Yao H.H., Ding J.H., Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology 2007, 32(12):2570-2580.
235. Zhou F., Yao H.H., Wu J.Y., Ding J.H., Sun T., Hu G. Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation. J. Cell. Mol. Med. 2008, 12(5A):1559-1570.
236. Zhou M., He H.J., Tanaka O., Sekiguchi M., Kawahara K., Abe H. Localization of the ATP-sensitive K(+) channel regulatory subunits SUR2A and SUR2B in the rat brain. Neurosci. Res. 2012, 74(2):91-105.
237. Zhou S.F., Wang L.L., Di Y.M., Xue C.C., Duan W., Li C.G., Li Y. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem. 2008, 15(20):1981-2039.
238. Zhu H.L., Luo W.Q., Wang H. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels. Neuroscience 2008, 157(4):884-894.
239. Zoga V., Kawano T., Liang M.Y., Bienengraeber M., Weihrauch D., McCallum B., Gemes G., Hogan Q., Sarantopoulos C. KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy. Mol. Pain 2010, 6:6.